Search
You are here : Home > About Us > Manchester
Sites and Locations

Manchester, England

In 2007, CARBOGEN AMCIS Ltd. was created with the integration of partner company SynProTec DCR, a custom synthesis company owned by Dishman Pharmaceuticals and Chemicals Ltd., the same parent company as CARBOGEN AMCIS. The Manchester site specializes in process research and custom synthesis of pharmaceutical intermediates. The larger production capacity (up to 4,500 L) allows the efficient production of early-phase APIs and large-scale intermediates. The facility employs 30 staff members.

 





Events
InformEx 2012

European Complience Academy Event on High Potency


Brochure
Download Company
Brochure here
News
16 January 2012
CARBOGEN AMCIS Acquires Creapharm Parenterals

19 October 2011
CARBOGEN AMCIS and Polymun Scientifc GmbH Sign Collaboration Agreement

4 October 2011
CARBOGEN AMCIS AG Appoints Villemagne as VP Commercial


Case Studies

CARBOGEN AMCIS is part of
a multi-site, global
organization, offering...
RSS Feed  
back   top   print